Share
5,159 Posts.
lightbulb Created with Sketch. 228
clock Created with Sketch.
28/03/16
15:51
Share
Originally posted by Madtrader
↑
Some hazy crystal ball gazing for H2 16 & full year....
- Cash receipts circa $64-66m for full year, with H2 receipts of $35-37m. This also depends on individual one-off portfolio sales that may occur.
- Revenue, based on these cash receipts, estimate will be in the region of $46-48m. This is dependent on underlying factors that could result in a change in overall portfolio valuation remaining largely the same (e.g. default rates, speed with which customers pay off etc.)
- Employee costs appear to be circa 45% of revenue so suggest full year costs in the region of $21m (incentives could skew this).
- Other costs would expect to be fairly linear (interest likely a bit more in second half) so say just over 2 x half year is circa $11.5m.
- Total profit before tax of $14.5m. Effective tax rate close to 30% so say PAT of $10m (this is greater than the current market guidance, which based on the wording appears to be the company's lower end).
Assuming no capital raising and thus generally consistent # of shares (there will be some additional from management incentive plans and dividend reinvestment plan) then this would mean EPS of 22-23c.
At a growth rate of 7% and a discount rate of 14% for 5 years (reversing out interest costs of say $2m for 2016FY) and then a discount rate of 14% and 0% growth for a further 10 years the PV (enterprise value) would be circa $147m, take off the $47m of debt and you get a value of shares of around $100m or circa $2.20 a share. With gearing structure, a 14% discount rate should include sufficient equity return. This is fairly crude, but does provide support for a value a fair bit higher than the current share price including a good degree of margin of safety (and thus potential). The next 1-3 years will be key in establishing how the business performs over a longer timeframe and, potentially, different business cycles.
A couple of things to watch/note in addition (to the above and prior post):
(a) the nominal cash flows in H1 16 coming from 1-2, 2-3 and 3+ years appear to have reduced compared to H2 15 (based on total receipts and the percentages included in the investor preso; %s also decreased); hopefully this isn't a negative trend...?
(b) Pricing discipline appears to have remained based on $23m pay for new debts and an increase in face value of $170m; this is positive and assume most of these purchases are the main reason for the increase in carrying value of the portfolio at 31/12 (which increased by a net of around $14m). Availability of appropriately priced debt will be key.
(c) I am a little concerned that non-scheduled PA vs Fixed Schedule PA information isn't disclosed for the first time in H16 investor preso: does this indicate a shift towards non-scheduled (less reliable) payments that the company doesn't want to show and are less reliable in terms of receipt?
(d) cost control and collection efficiency must be maintained/continue to improve, while maintaining the appropriate resource base to support the collection model/strategy. So far this seems to have been done responsibly.
One persons opinion, DYOR.
Expand
Great summery madtrader. If FY forecasts are achieved PNC looks great value at current prices.
The recent acquisition of https://www.switchmyloan.com.au/ for an undisclosed sum looks an interesting Fintech play though certainly not the main game.
Very much under the radar.